Jeena Sikho Lifecare to form Ayugenomics for genomics and Ayurveda
- Mergers & acquisitions
- Ayurveda
Reviewed byKeshav SehgalBlacklitt Research
Jeena Sikho Lifecare (NSE: JSLL) has approved incorporating a subsidiary, Ayugenomics Private Limited, to carry on "research, development, testing, diagnostics and clinical services that combine genomics and allied omics sciences with Ayurveda and other AYUSH systems of medicine", it said in a filing on 04 Nov 2026. The company will subscribe to 30,000 equity shares at ₹10 each, a total of ₹3 lakh, for a 60% holding.
The subsidiary's stated business and capital
The board approved the proposal at a meeting on 04 Nov 2026, subject to statutory approvals and completion of incorporation formalities. Ayugenomics Private Limited is yet to be incorporated, and its proposed authorised share capital is ₹5 lakh, divided into 50,000 equity shares of ₹10 each.
The entity will develop genomics-based panels, tests and software, run clinical studies, and develop and commercialise evidence-based herbal, nutraceutical and botanical products. It will also offer wellness and training programmes and seek patents and registrations in India and abroad, including from CDSCO and the US FDA.
Once incorporated, the subsidiary will be a related party of the company. It will work with hospitals, government and state programmes, and institutions in Japan and other overseas markets.
What the subsidiary means for Jeena Sikho Lifecare's shareholders
The company's outlay is ₹3 lakh in cash through the banking channel, for 60% of the subsidiary's equity. The filing does not say who holds the rest of the equity, when the entity will be incorporated, what funding it will need beyond the initial subscription, or what effect it will have on the company's results.
At a glance
| Item | Detail |
|---|---|
| Subsidiary | Ayugenomics Private Limited (proposed, India) |
| Board approval | 04 Nov 2026 |
| Authorised share capital | ₹5 lakh, 50,000 equity shares of ₹10 each |
| Company's subscription | 30,000 equity shares at ₹10 each, ₹3 lakh |
| Holding | 60% of equity |
| Stated business | Genomics combined with Ayurveda and AYUSH systems |
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
